Apoptosis and necrosis in liver disease

Liver International

Volumn 24, Issue 2, 2004, Pages 85-89

  Jaeschke, Hartmut ^a   Gujral, Jaspreet S ^a   Bajt, Mary Lynn ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Acetaminophen; Apoptosis; Cell death; Cholestasis; Drug induced liver injury necrosis; Liver disease; Troglitazone; Viral hepatitis

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CYTOCHROME C; DNA FRAGMENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PARACETAMOL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEIN BCL 2; TROGLITAZONE;

ANIMAL MODEL; APOPTOSIS; CELL DEATH; CHOLESTASIS; CONFUSION; DIGESTIVE TRACT PARAMETERS; DRUG OVERDOSE; HEPATITIS B; HEPATITIS C; HUMAN; IN VIVO STUDY; LIVER CELL; LIVER CELL DAMAGE; LIVER NECROSIS; LIVER PROTECTION; LIVER TOXICITY; MOUSE; NICK END LABELING; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; VIRUS HEPATITIS;

EID: 2342529871     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2004.0906.x     Document Type: Review

References (40)

1. Galle P R, Krammer P H. CD95-induced apoptosis in human liver disease. Semin Liver Dis 1998; 18: 141-51.
2. Jaeschke H, Lemasters J J. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 2003; 125: 1246-57.
3. Kerr J F, Wyllie A H, Currie A R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-57.
4. Lemasters J J. V. Necrapoptosis and the mitochondrial permeability transition: shared pathways to necrosis and apoptosis. Am J Physiol 1999; 276: G1-6.
5. Jaeschke H. Inflammation in response to hepatocellular apoptosis. Hepatology 2002; 35: 964-6.
6. Patel T, Bronk S F, Gores G J. Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes. J Clin Invest 1994; 94: 2183-92.
7. Rodrigues C M, Fan G, Wong P Y, Kren B T, Steer C J. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol Med 1998; 4: 165-78.
8. Rust C, Karnitz L M, Paya C V, Moscat J, Simari R D, Gores G J. The bile acid taurochenodeoxycholate activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade. J Biol Chem 2000; 275: 20210-6.
9. Schoemaker M H, Gommans W M, De La Rosa L C, Homan M, Klok P, Trautwein C, Van Goor H, Poelstra K, Haisma H J, Jansen P L, Moshage H. Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation. J Hepatol 2003; 39: 153-61.
10. Gujral J S, Farhood A, Jaeschke H. Apoptosis and oncotic necrosis during acute liver injury after bile duct ligation in mice. Hepatology 2003; 38(Suppl. 1): 240A.
11. Fickert P, Trauner M, Fuchsbichler A, Zollner G, Wagner M, Zenz R, Zsengeller Z, Szabo C, Denk H. Inhibition of poly(ADP-ribose) polymerase (PARP) protects mice from cholestatic liver injury. Hepatology 2003; 38(Suppl. 1): 576A.
12. Bajt M L, Lawson J A, Vonderfecht S L, Gujral J S, Jaeschke H. Protection against Fas receptor-mediated apoptosis in hepatocytes and nonparenchymal cells by a caspase-8 inhibitor in vivo: evidence for a postmitochondrial processing of caspase-8. Toxicol Sci 2000; 58: 109-17.
13. Miyoshi H, Rust C, Guicciardi M E, Gores G J. NF-kappaB is activated in cholestasis and functions to reduce liver injury. Am J Pathol 2001; 158: 967-75.
14. Miyoshi H, Rust C, Roberts P J, Burgart L J, Gores G J. Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. Gastroenterology 1999; 117: 669-77.
15. Gujral J S, Farhood A, Bajt M L, Jaeschke H. Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice. Hepatology 2003; 38: 355-63.
16. Canbay A, Guicciardi M E, Higuchi H, Feldstein A, Bronk S F, Rydzewski R, Taniai M, Gores G J. Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. J Clin Invest 2003; 112: 152-9.
17. Jaeschke H, Knight T R, Bajt M L. The role of oxidant stress and reactive nitrogen species in acetaminophen hepatotoxicity. Toxicol Lett 2003; 144: 279-88.
18. Ray S D, Mumaw V R, Raje R R, Fariss M W. Protection of acetaminophen-induced hepatocellular apoptosis and necrosis by cholesteryl hemisuccinate pretreatment. J Pharmacol Exp Ther 1996; 279: 1470-83.
19. Lawson J A, Fisher M A, Simmons C A, Farhood A, Jaeschke H. Inhibition of Fas receptor (CD95)-induced hepatic caspase activation and apoptosis by acetaminophen in mice. Toxicol Appl Pharmacol 1999; 156: 179-86.
20. Knight T R, Jaeschke H. Acetaminophen-induced inhibition of Fas receptor-mediated liver cell apoptosis: mitochondrial dysfunction versus glutathione depletion. Toxicol Appl Pharmacol 2002; 181: 133-41.
21. Adams M L, Pierce R H, Vail M E, White C C, Tonge R P, Kavanagh T J, Fausto N, Nelson S D, Bruschi S A. Enhanced acetaminophen hepatotoxicity in transgenic mice overexpressing BCL-2. Mol Pharmacol 2001; 60: 907-15.
22. El-Hassan H, Anwar K, Macanas-Pirard P, Crabtree M, Chow S C, Johnson V L, Lee P C, Hinton R H, Price S C, Kass G E. Involvement of mitochondria in acetaminophen-induced apoptosis and hepatic injury: roles of cytochrome c, Bax, Bid, and caspases. Toxicol Appl Pharmacol 2003; 191: 118-29.
23. Gujral J S, Knight T R, Farhood A, Bajt M L, Jaeschke H. Mode of cell death after acetaminophen overdose in mice: apoptosis or oncotic necrosis? Toxicol Sci 2002; 67: 322-8.
24. Lee W M. Drug-induced hepatotoxicity. N Engl J Med 2003; 349: 474-85.
25. Schotte P, Declercq W, Van Huffel S, Vandenabeele P, Beyaert R. Non-specific effects of methyl ketone peptide inhibitors of caspases. FEBS Lett 1999; 442: 117-21.
26. Limaye P B, Apte U M, Shankar K, Bucci T J, Warbritton A, Mehendale H M. Calpain released from dying hepatocytes mediates progression of acute liver injury induced by model hepatotoxicants. Toxicol Appl Pharmacol 2003; 191: 211-6.
27. Graham D J, Drinkard C R, Shatin D. Incidence of idiopathic acute liver failure and hospitalized liver injury in patients treated with troglitazone. Am J Gastroenterol 2003; 98: 175-9.
28. Yamamoto Y, Nakajima M, Yamazaki H, Yokoi T. Cytotoxicity and apoptosis produced by troglitazone in human hepatoma cells. Life Sci 2001; 70: 471-82.
29. Bae M A, Song B J. Critical role of c-Jun N-terminal protein kinase activation in troglitazone-induced apoptosis of human HepG2 hepatoma cells. Mol Pharmacol 2003; 63: 401-8.
30. Kawai K, Kawasaki-Tokui Y, Odaka T, Tsuruta F, Kazui M, Iwabuchi H, Nakamura T, Kinoshita T, Ikeda T, Yoshioka T, Komai T, Nakamura K. Disposition and metabolism of the new oral antidiabetic drug troglitazone in rats, mice and dogs. Arzneim Forsch/Drug Res 1997; 47: 356-8.
31. Caldwell S H, Hespenheide E E, Redick J A, Iezzoni J C, Battle E H, Sheppard B L. A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis. Am J Gastroenterol 2001; 96: 519-5.
32. Boulares A H, Zoltiski A J, Stoica B A, Cuvillier O, Smulson M E. Acetaminophen induces a caspase-dependent and Bcl-XL sensitive apoptosis in human hepatoma cells and lymphocytes. Pharmacol Toxicol 2002; 90: 38-50.
33. Nagai H, Matsumaru K, Feng G, Kaplowitz N. Reduced glutathione depletion causes necrosis and sensitization to tumor necrosis factor-alpha-induced apoptosis in cultured mouse hepatocytes. Hepatology 2002; 36: 55-64.
34. Hayashi N, Mita E. Involvement of Fas system-mediated apoptosis in pathogenesis of viral hepatitis. J Viral Hepat 1999; 6: 357-65.
35. Kountouras J, Zavos C, Chatzopoulos D. Apoptosis in hepatitis C. J Viral Hepat 2003; 10: 335-42.
36. Pianko S, Patella S, Ostapowicz G, Desmond P, Sievert W, Fas-mediated hepatocyte apoptosis is increased by hepatitis C virus infection and alcohol consumption, and may be associated with hepatic fibrosis: mechanisms of liver cell injury in chronic hepatitis C virus infection. J Viral Hepat 2001; 8: 406-13.
37. Rivero M, Crespo J, Fabrega E, Casafont F. Mayorga M, Gomez-Fleitas M, Pons-Romero F. Apoptosis mediated by the Fas system in the fulminant hepatitis by hepatitis B virus. J Viral Hepat 2002; 9: 107-13.
38. Rubbia-Brandt L, Taylor S, Gindre P, Quadri R, Abid K, Spahr L, Negro F. Lack of in vivo blockade of Fas- and TNFR1-mediated hepatocyte apoptosis by the hepatitis C virus. J Pathol 2002; 197: 617-23.
39. Bantel H, Lugering A, Poremba C, Lugering N, Held J, Domschke W, Schulze-Osthoff K. Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection. Hepatology 2001; 34: 758-67.
40. Ibuki N, Yamamoto K, Yabushita K, Okano N, Okamoto R, Shimada N, Hakoda T, Mizuno M, Higashi T, Tsuji T. In situ expression of Granzyme B and Fas-ligand in the liver of viral hepatitis. Liver 2002; 22: 198-204.